Sign in
PBE Stock Price, Chart, Stats & News
Invesco Biotechnology & Genome ETF
Save
Invesco Biotechnology & Genome ETF (PBE) does not currently pay a dividend.
Health
Category
0.58%
Expense ratio
257.89M
Assets
31.27%
1Y return
PBE chart
1M
3M
1Y
5Y
Loading chart...
PBE returns
| YTD | 1.73% |
| 1Y | 31.27% |
| 3Y | 10.97% |
| 5Y | 3.29% |
| 10Y | 7.67% |
| 1Y volatility | 13.99% |
| 3Y volatility | 16.88% |
| Sharpe ratio | 0.48 |
About
The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation.
Top 10 PBE holdings
| Holding | Ownership |
|---|---|
Health care 5.11% | |
Health care 5.08% | |
Health care 4.84% | |
Health care 4.74% | |
Health care 4.52% | |
Health care 4.47% | |
Health care 4.34% | |
Health care 4.26% | |
Health care 3.66% | |
Health care 3.39% |
Similar securities
Based on sector and market capitalization
Report issue